Last update 08 May 2025

Valergen-DP

Overview

Basic Info

Drug Type
Biological products
Synonyms-
Target-
Action
modulators
Mechanism
Mite allergen modulators
Therapeutic Areas
Immune System DiseasesRespiratory Diseases
Active Indication-
Inactive Indication
Asthma
Originator Organization
The National Center for Biopreparations
Active Organization-
Inactive Organization
The National Center for Biopreparations
License Organization-
Drug Highest PhasePendingPhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

5
Clinical Trials associated with Valergen-DP
RPCEC00000240
/ RecruitingPhase 2IIT
Clinical trial of combined immunotherapy con with allergenic extracts Dermatophagoides pteronyssinus (VALERGEN-DP) and Blomia tropicalis (VALERGEN-BT) by sublingual route in sensitized asthmatic adults (version 1.3).
ChiCTR-TRC-14004696
/ RecruitingPhase 1IIT
Randomized study of first-line pemetrexed (Pe) plus platinum (P) followed by second-line docetaxel (D) versus first-line DP followed by second-line Pe in advanced non-small cell lung cancer
RPCEC00000127
/ SuspendedPhase 2IIT
Clinical trial with allergenic extracts Dermatophagoides pteronyssinus (VALERGEN-DP) and Blomia tropicalis (VALERGEN-BT) by subcutaneous therapeutic use in sensitized asthmatic adults. Version 04.” - SCIT-C-VALERGEN-DP-BT-Asthma-Adults-Phase II
100 Clinical Results associated with Valergen-DP
Login to view more data
100 Translational Medicine associated with Valergen-DP
Login to view more data
100 Patents (Medical) associated with Valergen-DP
Login to view more data
100 Deals associated with Valergen-DP
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
AsthmaPhase 2-
The National Center for Biopreparations
-
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
ASCO2012
Phase 1
Metastatic castration-resistant prostate cancer
14
iatlfaudmv(swytqckqgh) = uogzjhpiot inczgwmrgd (znmxxfdhys )
View more
-
20 May 2012
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free